Category: CytoSorbents

https://www.tipranks.com/news/the-fly/cytosortents-reported-strong-q4-results-says-d-boral-capital D. Boral Capital CytoSorbens says (CTSO) posted a strong performance in the fourth quarter, with product revenue growing between 22% and 25% year over year. The company also showed a significant rebound in gross profit margin to around 70%, underscoring operational resilience and efficiency improvements, the analyst told investors…